Tricuspid valve replacement outcomes by baseline tricuspid regurgitation severity: the TRISCEND II trial

Patients with ≥severe TR benefit from TTVR, experiencing improvements in TR severity, functional capacity, and quality of life regardless of baseline TR severity, with a signal for greater benefit in patients with more advanced disease.

Authors

Institutions

Publication Details

Journal
European Heart Journal
Published
2025-08-29
DOI
https://doi.org/10.1093/eurheartj/ehaf676
Citations
14
Primary Topic
Cardiac Valve Diseases and Treatments
Type
article
Field-Weighted Citation Impact
19.43

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Tricuspid valve replacement outcomes by baseline tricuspid regurgitation severity: the TRISCEND II trial

Hartmut Herrmann, Paul Grayburn, Vinod H. Thourani, Georg Nickenig et al.
14 citations
European Heart Journal
Cardiac Valve Diseases and Treatments
19.43
article

Tricuspid valve replacement outcomes by baseline tricuspid regurgitation severity: the TRISCEND II trial

Hartmut Herrmann, Paul Grayburn, Vinod H. Thourani, Georg Nickenig, Volker Rudolph, Molly Szerlip, Robert Allen Smith, Vasilis Babaliaros, Jacob M. Mishell, Michael J. Mack, Susheel Kodali, Colin M. Barker, William A. Gray, Anna Sannino, Scott Lim, Pinak Shah, Adnan K. Chhatriwalla, Ignacio Inglessis‐Azuaje, Brian O’Neill, Raj Makkar, Mackram F. Eleid, Matthew Summers, George Petrossian, Abhijeet Dhoble, Jörg Hausleiter, Tobias Kister, Stephan Baldus, Azeem Latib, Rebecca Tung Hahn, Gagan D. Singh, Ralph Stephan von Bardeleben, Andrew N. Rassi, Brian R. Lindman, John Saxon, Philipp Lurz, Robert Kipperman, Justin A Strote, Firas Zahr, Cezar Staniloae, Curtiss Stinis, Mathew Williams, Stanley Chetcuti, Bassem Chehab, Brian Whisenant, Kamran I. Muhammad, Samir Kapadia, Pradeep Yadav, C.T. Klodell, Scott Chadderdon, James M. McCabe, Rahul Sharma, Charles J. Davidson, Gorav Ailawadi, Mark Russo, Martin B. Leon, Michael Rinaldi, Marcos Nores, Wilson Y. Szeto, James Hermiller, Santiago Garcia, Ilie Barb
article en
14 citations

Abstract

Patients with ≥severe TR benefit from TTVR, experiencing improvements in TR severity, functional capacity, and quality of life regardless of baseline TR severity, with a signal for greater benefit in patients with more advanced disease.

European Heart Journal
Rutgers, The State University of New Jersey (US), Northwestern University (US), Cedars-Sinai Medical Center (US), Brigham and Women's Hospital (US), Sentara Norfolk General Hospital (US), Cleveland Clinic (US), Valve (United States) (US), Ascension (US), Mayo Clinic (US), UF Health Shands Hospital (US), Montefiore Medical Center (US), University of Kansas (US), Emory University (US), Oregon Health & Science University (US), Johannes Gutenberg University Mainz (DE), University of Washington (US), University of Michigan (US), University Hospital Bonn (DE), Columbia University Irving Medical Center (US), Cleveland Foundation (US), St Vincent Hospital (US), Piedmont Atlanta Hospital (US), Johnson University (US), Lankenau Medical Center (US), Morristown Medical Center (US), Saint Vincent Health System (US), Henry Ford Hospital (US), Intermountain Medical Center (US), LMU Klinikum (DE), NYU Langone Health (US), Massachusetts General Hospital (US), John F. Kennedy Medical Center (US), The Bronx Defenders (US), Oklahoma Heart Institute (US), University Medical Center of the Johannes Gutenberg University Mainz (DE), St. Francis Hospital (US), Northwestern University (PH), St. Vincent Hospital (US), Atrium Medical Cente (US), Scripps Memorial Hospital (US), Heart Hospital Baylor Plano (US), Michigan Medicine (US), Sentara Heart Hospital (US), Leipzig Heart Institute (DE), Kaiser Permanente San Francisco Medical Center (US), Mayo Clinic in Arizona (US), The Cardiac and Vascular Institute (US), Christ Hospital (US), Ascension Via Christi Hospital (US), Stanford Medicine (US), Saint Luke's Hospital (US), Cedars-Sinai Smidt Heart Institute (US), Northwestern Medicine (US), Ascension Via Christi (US), University Hospital Cologne (DE), Klinik Bad Oexen (DE), Christ Hospital (US), University of California Davis Medical Center (US), Advocate Heart Institute (US), University of Virginia (US), University of Colorado Anschutz Medical Campus (US), Atlantic Health System (US), University of Pennsylvania (US), Vanderbilt University Medical Center (US), The University of Texas Health Science Center at Houston (US), Stanford University (US), Core Laboratories (United States) (US)
Edwards Lifesciences, Max-Planck-Institut für Astronomie
Openalex Percentile: Top 0%
Cardiac Valve Diseases and Treatments
19.43
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.